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Abstract
We gave questionnares to 503 female students （326 athletes, 177 non athletes） regarding 
their willingness to receive novel influenza A （H1N1） vaccine. A chi-squared test was used to 
examine the characteristics between athletic and non-athletic students based on their answers.
A total of 261 students （51.9%） answered that they did not want to receive the vaccine, 
while willingness to accept the vaccine was significantly greater among non-athletic （56.5%） as 
compared to athletic （43.6%） students. That finding might have been due the necessities of 
vaccitinization for other viruses such as rubella and measles, causing them miss taking an im-
portant examination to acquire a registered dietitian certificate. Consciousness of accepting oth-
er viral vaccines might be related to acceptance of receiving the novel influenza A （H1N1） vac-
cine. In addition, our results suggest that non-athletic students have a higher level of 
consciousness of being willing to receive both the new influenza A （H1N1） vaccine and seasonal 
influenza vaccine.
The athletic students in our study showed a higher level of willingness to receive the sea-
sonal influenza vaccine, which may contribute to preventing seasonal influenza from spreading 
among athletes. Individuals not willing to receive the novel influenza A （H1N1） vaccine should 
clearly understand that they do not have substantial cross tolerance from receiving the seasonal 
influenza vaccination. Students in both groups showed a favorable attitude in 2009 for the H1N1 
vaccination, though further study is needed.
Ⅰ Introductions
A novel influenza A virus has been identified 
as the cause of outbreaks of feverish respiratory 
tract infections ranging from self-limited to severe 
illness１. That study noted that in April 2009, a 
novel influenza A （H1N1） virus started to spread 
in North America causing upper and lower respi-
ratory tract infections. Molecular characterization 
of the virus by the U.S. Centers for Disease Con-
trol （CDC） revealed that the circulating virus was 
a completely novel recombinant of previously iden-
tified viruses with various avian, pig and human 
origins1. Then, on June 11, 2009, the World Health 
Organization declared that an influenza pandemic 
was under way, after which the new influenza A 
virus spread rapidly throughout more than 70 
countries. Based on the evidence of the efficacy of 
vaccination for control and prevention of seasonal 
influenza２, ３, vaccination for pandemic influenza is 
an important primary preventative method to 
avoid the risks associated with influenza A infec-
tion４.
The first domestic infection of the new strain 
of influenza A in Japan was reported on May 21, 
2009 prompting the government to take actions to 
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Science and Nutrition （n=177）, and all were fe-
male. Inclusion criteria were enrollment as a stu-
dent and willingness to participate in the research 
study. The questionnaire was offered on a volun-
tary and anonymous basis to undergraduate stu-
dents at class and organizational meetings. The 
survey instrument was designed to be brief, nonin-
trusive, with height and weight not asked, and 
easy to complete in order to ensure a high re-
sponse rate. Written informed consent was ob-
tained from all students who participated.
In this study, we defined the students of the 
Department of Health and Sports Sciences as ath-
letic students and those of the Department of Food 
Science and Nutrition as non-athletic students. Stu-
dents of the Department of Food Science and Nu-
trition who routinely participated in sports activi-
ties were placed in non-athletic student group, 
while those of the the Department of Health and 
Sports Sciences who did not routinely participate 
in sports activities were placed in the athletic stu-
dent group.
Since this was not an experimental or inter-
ventional study, ethical committee approval was 
not required. Subjects were recruited during the 
breaking time before lectures and after lectures 
during the 1-week period from October 10-17, 2009, 
just prior to the beginning of vaccination campaign 
of novel influenza A. Students who agreed to par-
ticipate were given the study questionnaires to 
complete on their own and a total of 503 returned 
completed the questionnaires.
Ⅲ Questionnaires
The questions used in the questionnaire to de-
termine willingness to accept the influenza A
（H1N1） vaccination were as follow Question 1 “Will 
you receive the new influenza A （H1N1） vac-
cine?”, Question 2 “Will you receive both the new 
influenza A （H1N1） vaccine and seasonal influenza 
vaccine?” Question 3 “Will you receive only the 
seasonal influenza vaccine?”, Question 4 “Have you 
address the threat, including closure of some 
schools amid signs of further expansion （Japan To-
day: Sunday 22nd May, 01:22 AM JST）. At that 
tome, 3 students from a high school in Kobe, Hyo-
go Prefecture, with no recent history of traveling 
overseas, were confirmed as being infected, while 
5 students at a different high school in the city 
were also later found to be infected. There were 
also suspected cases in Osaka Prefecture. The out-
break came despite attempts by the Japanese gov-
ernment to block entry of the virus through quar-
antines at airports. Four cases had been found 
through health inspections at Narita International 
Airport among a group of Japanese students and 
teachers who arrived May 8 on a flight from the 
United States after a trip to Canada （cited text 
partly omitted）. In addition to the 3 students Kobe 
High School a 17-year-old male, 16-year-old male 
and 16-year-old female, 17 other students at the 
same school reported feeling sick, while more than 
10 students from other schools in the prefecture 
developed a fever after playing volleyball with the 
infected student, according to local authorities （Ja-
pan Today Sunday 22nd May, 01:22 AM JST: 2009 
Kyodo News）.
Sports activities such as volleyball or basket-
ball as well as other sports that feature close con-
tact, may easily spread an influenza virus from an 
infected player. That it is very important for ath-
letes to not spread airborne infections while prac-
ticing and playing games. In the present study, we 
evaluated the results of questionnaires concerningt 
the willingness of Japanese athletic or non-athletic 
students to accept a novel H1N1 influenza A vac-
cine made available in 2009. 
Ⅱ Methods
Participants and Survey Methods
Subjects of the present study were recruited 
by convenience sampling conducted at Mukogawa 
Women’s University, Department of Health and 
Sports Sciences （n=326） and Department of Food 
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Ⅴ Results
As for the overall willingness to acceptthe 
novel influenza A （H1N1） vaccination, 242 stu-
dents （48.1%） answered that they would receive 
（Fig.1）.That willingness was found in significantly 
larger proportion of the non-athletic students 
（56.5%） as compared to in athletic students 
（43.6%） （Fig.2）.
The proportion of students willing to receive 
both the new influenza A （H1N1） vaccine and sea-
sonal influenza vaccine among the non-athletic 
group （32.2%） was also significantly greater than 
that of the athletic group（21.1%） （Fig.3）. How-
ever, the proportion of students who answered 
that were willing to receive only the seasonal influ-
received the seasonal influenza vaccine for these 
five years”, Question 5 “Have you infected influen-
za for these five months?”.
Ⅳ Statistical analysis
A chi-squared test was used to examine the 
characteristics between the athletic and non-athlet-
ic students that were willing to accept the influen-
za A （H1N1） vaccination against those who were 
not willing to accept the vaccine （Question 1）. A 
chi-squared test was also used to examine the 
characteristics of the answers to question numbers 
2 to 4 between the athletic and non-athletic stu-
dents. The level of statistical significance was set 
at p＜0.05.
Figure １.  Willingness to accept novel vaccination （n＝503）
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Figure ２.  Willingness to accept novel influenza vaccination. Comparison 
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Figure ３.  Comparison of number of students willing to receive both new 
influenza A （H1N1） vaccine and seasonal influenza between 
non-athletic and athletic students. 
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Figure ４.  Comparison of number of students willing to receive only seasonal 
influenza vaccine between non-athletic and athletic students. 
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Figure ５.  Comparison of number of students who received seasonal vaccination 
in past 5 years between athletic and non-athletic students.
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In contrast to that study, general practitioners 
working in a community in France had a high rate 
of acceptability （62%） of the influenza A （H1N1） 
vaccination6. In another study of medical workers, 
67% of physicians and 31% of nurses indicated 
their acceptance to receive vaccinated against the 
pandemic H1N1 influenza in 2009 （p<0.001）7. In 
contrast, that study also reported that nurses were 
more prone （79.5%） than physicians （64.7%） to 
wash their hands or use hand sanitizers more fre-
quently in response to reports of pandemic influen-
za （p＜0.001）. Our result （56%） showing the 
greater willingness among non-athletic students to 
accept the novel influenza A （H1N1） vaccine 
might have been related to necessities of vaccitini-
zation for other viruses such as rubella and mea-
sles prior to the examination and to acquire the 
registered dietitian certificate. Consciousness of ac-
ceptance other viral vaccines might be lead to the 
acceptance of the novel influenza A （H1N1） vac-
cine. Our findings also demonstrated that non-ath-
letic students have a higher level of consciousness 
of willing to receive both the new influenza A 
（H1N1） and seasonal influenza vaccines.
We found that athletic students were more 
willing to receive the seasonal influenza vaccine, 
which may contribute to preventing seasonal influ-
enza from spreading among athletes. If athletic 
enza vaccine was significantly higher among ath-
letic （28.5%） as compared to non-athletic （13.4%） 
students （Fig.4）.
There was no significant difference in seasonal 
vaccinations during the past 5 years between the 
athletic （76.4%） and non-athletic （69.5%） stu-
dents （Fig.5）. There was also no significant differ-
ence in the percentage who had influenza in the 
past 5 months between athletic （yes: 5.2%, no: 
94.8%） and non-athletic （yes: 9.0%, no: 91.0%） 
students （Fig.6）.
Ⅵ Discussion
In the present study, 261 of all students 
（51.9%） answered that they did not want to re-
ceive the novel influenza A （H1N1） vaccine, 
though the willingness to receive vaccine was sig-
nificantly greater in non-athletic （56%） than ath-
letic （44%） students. In a previous study of nurses, 
194 （73%） participants did not want to receive the 
novel influenza A （H1N1） vaccine5. That study in-
vestigate the characteristics of respondents who 
were willing and not willing to receive the vaccina-
tion using chi-squared test. Nurses willing to re-
ceive influenza A （H1N1） vaccine were different 
with respect to “being vaccinated against seasonal 
influenza vaccination in the previous 12 months.” 
Figure ６.  Comparison of number of students with influenza in past ５ 
months between athletic and non-athletic students.
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and the CDC recommends that all individuals 6 
months and older receive the 2010-2011 flu vaccine 
for the upcoming season, as it is available （http://
www.cdc.gov/H1N1flu/）.
Based on the present results, we recommend 
that athletes receive the influenza virus vaccine in 
order to avoid spreading of the disease. In addition, 
correct information regarding influenza vaccina-
tions is important for athletic students.
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